Apellis Pharmaceuticals is a biopharmaceutical company developing complement-immunology therapies for retinal, hematologic, and other rare diseases.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| George Soros / Soros Fund Mgmt | 31 | New buy | 1,056,000 | $42,482,880 | 0.5% |
| Bridgewater | 55 | Trimmed -76% | 34,913 | $1,404,550 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.